As I have said, there is some good that can come from the video, but approval is not a popularity contest, particularly for a non-rev bio. Without approval we are a struggling OTC with a sexy molocule and a noisy fan base that has had the fecal matter slapped out of it for making too much similar noise by the ruling agency. If we hit our endpoints MDs and hospitals will know it and move with it and the public will know about it too, just like they know about other approved drugs. Until there is approval videos like this one are just more noise from the cheapseats. However, if it gives shareholders the warm fuzzyies and helps others buy shares then it is serving a purpose just the same.

All in my very cheap opinion.